Preparation of a solid dispersion of felodipine using a solvent wetting method

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 64, Issue 2, 2006, Pages 200-205

  Kim, Eun Jung ^a   Chun, Myung Kwan ^a   Jang, Jae Sang ^a   Lee, In Hwa ^a   Lee, Kyeo Re ^a   Choi, Hoo Kyun ^a  

^a Chosun University   (South Korea)

Author keywords

Dissolution; Felodipine; Poorly water soluble; Solid dispersion; Solvent wetting method

Indexed keywords

ALCOHOL; DICHLOROMETHANE; FELODIPINE; HYDROXYPROPYLMETHYLCELLULOSE; LUTROL; MANNITOL; POLOXAMER; POVIDONE; SORBITOL;

ARTICLE; CHEMICAL PROCEDURES; CRYSTAL STRUCTURE; DISPERSION; DISSOLUTION; DRUG SOLUBILITY; STATISTICAL SIGNIFICANCE; THERMAL ANALYSIS; X RAY DIFFRACTION;

CALCIUM CHANNEL BLOCKERS; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; ETHANOL; FELODIPINE; MANNITOL; METHYLCELLULOSE; METHYLENE CHLORIDE; POLOXAMER; POVIDONE; POWDER DIFFRACTION; SOLUBILITY; SOLVENTS; SORBITOL; TIME FACTORS; TRANSITION TEMPERATURE; WETTABILITY;

EID: 33747888621     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.04.001     Document Type: Article

References (23)

1. American Hospital Formulary Service drug information. American Society of Health-system Pharmaceutics, Bethesda, MD, 1998, pp. 1483-1484.
2. Wingstrand K., Abrahamson B., and Edgar B. Bioavailability from felodipine extended-release tablets with different dissolution properties. Int. J. Pharm. 60 (1900) 151-156
3. Chiou W.L., and Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60 (1971) 1281-1302
4. Ford J.L. The current status of solid dispersions. Pharm. Acta Helv. 61 (1986) 69-88
5. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50 (2000) 47-60
6. Craig D.Q.M. The mechanism of drug release from solid dispersion in water-soluble polymers. Int. J. Pharm. 231 (2002) 131-144
7. Taylor L.S., and Zografi G. Spectroscopic characterization interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14 (1997) 1691-1698
8. Yamashita K., Nakate T., Okimoto K., Ohike A., Tokunaga Y., Ibuki R., Higaki K., and Kimura T. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm. 267 (2003) 79-91
9. Moneghini M., Carcano A., Zingone G., and Perissutti B. Studies in dissolution enhancement of atenolol. Part I. Int. J. Pharm. 175 (1998) 177-183
10. Abdul-Fattah A.M., and Bhargava H.N. Preparation and in vitro evaluation of solid dispersions of halofantrine. Int. J. Pharm. 235 (2002) 17-33
11. Sekikawa H., Nakano M., and Arita T. Inhibitory effect of polyvinylpyrrolidone on the crystallization of drugs. Chem. Pharm. Bull. 26 (1978) 118-126
12. Yagi N., Terashima Y., Kenmotsu H., Sekikawa H., and Takada M. Dissolution behavior of probucol from solid dispersion systems of probucol-polyvinylpyrrolidone. Chem. Pharm. Bull. 44 (1996) 241-244
13. Kohri N., Yamayoshi Y., Xin H., Iseki K., Sato N., Todo S., and Miyazaki K. Improving the oral bioavailability of albendazol in rabbits by the solid dispersion technique. J. Pharm. Pharmacol. 51 (1999) 159-164
14. Kobayashi M., Sada N., Sugawara M., Iseki K., and Miyazaki K. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. Int. J. Pharm. 221 (2001) 87-94
15. ICH Harmonized tripartite guideline, Impurities: Guideline for Residual Solvents, The Fourth International Conference on Harmonization, 17, 1997.
16. Ishikawa T., Watanabe Y., Takayama K., Endo H., and Matsumoto M. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of poorly water-soluble drug from tablets prepared using macrogol and HPMC. Int. J. Pharm. 202 (2000) 173-178
17. Katzhendler I., Azoury R., and Friedman M. Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose. J. Control Rel. 54 (1998) 69-85
18. Shin S.C., and Cho C.W. Physicochemical characterizations of piroxicam-poloxamer solid dispersion. Pharm. Dev. Tech. 2 (1997) 403-407
19. Vippagunta S.R., Maul K.A., Tallavajhala S., and Grant D.J.W. Solid-state characterization of nifedipine solid dispersion. Int. J. Pharm. 236 (2002) 111-123
20. Wade A., and Weller P.J. Handbook of Pharmaceutical Excipients. 2nd ed. (1994), American Pharmaceutical Association, Washington, DC
21. Savolainen M., Herder J., Khoo C., Lovqvist K., Dahlqvist C., Glad H., and Juppo A.M. Evaluation of polar lipid-hydrophilic polymer microparticles. Int. J. Pharm. 262 (2003) 47-62
22. Jachowicz R. Dissolution rates of partially water-soluble drugs from solid dispersion systems. I. Prednisolone Int. J. Pharm. 35 (1987) 1-5
23. Okonogi S., Yonemochi E., Oguchi T., Puttipipatkhachorn S., and Yamamoto K. Enhanced dissolution of ursodeoxycholic acid from the solid dispersion. Drug Dev. Ind. Pharm. 23 (1997) 1115-1121